Abstract:
I.
Introduction:
Dispersible tablets are uncoated tablets that produce a uniform dispersion or suspension in water at room temperature without stirring. With the increase in the average human life span, drug administration for elderly patients has become more important. Due to decline in swallowing ability with age; a great many elderly patients complain that it is difficult to take medication in the form of tablets. Recently useful dosage form such as rapidly disintegrating or dissolving tablet, have been developed & applied clinically. The dispersible tablets allow dissolution or dispersion in water prior to administration. Dispersible tablets are easier to administer or swallow than capsules for pediatric, dysphasic patients, mentally ill, unco-operative and nauseated patients, those with conditions of motion sickness, sudden episodes of allergic attack or coughing. Sometimes it may be difficult to swallow conventional products due to unavailability of water. Roxithromycin is a white or, crystalline powder, which is freely soluble in chloroform,acetone,ethanol ,methanol insoluble in water .It has a melting point of 115−125℃, it posses pH ranges upto 8-10.
The present investigation was carried out to prepare dispersible tablets of roxithromycin using MCC,primogel(cross Na starch glycolate,deprogel,explotab),accogel(cross caramellose,cross linked Na CMC),kollidone(cross povidone) as asuper disintegrants to establish standards required for the dispersible tablet, to optimize the effective concentration of the disintegrant and to compare the formulations with marketed product.
Materials and Methods:
Roxithromycin was provided as a gift sample by Alkem lab.t. ltd. & Daman, Primogel,kollidone,accogel was provided by cipla lab. ltd.. All the materials used were of standard analytical grade.
II.

Method:
A) Preparation of Dispersible Tablet [10-12]:
Dispersible tablets of Roxithromycin were prepared using direct compression method after incorporating different disintegrant named as Roxithromycin, Primogel, Kollidone, Cassia Tora, Accga, Mcc, Laclose, Talc, Mag. Stearate, in a concentration 4%. The composition of formulation is given in Table No 1. The ingredients were thoroughly mixed and passed through sieve no. 22. 
Table1: Formulation of Dispersible Tablet of Norfloxacin
B) Evaluation of Formulated Tablet:
The various formulations were evaluated for hardness, weight variation, friability, disintegration time, Invitro disintegration time, wetting time, uniformity of dispersion, drug content/content uniformity, and dissolution study.
Disintegration time was determined using Thermonic Tablet Disintegration apparatus USP using distilled water as a disintegration medium. Each formulation was tested for uniform dispersion as per official standards. After disintegration beaker was shaken and this fluid was passed through the sieve no.22. Hardness of the tablet was tested Pfizer hardness tester and friability by Roche Friabilator. Drug content was determined by using UV spectrometer (Shimadzu) at 263 nm. Theevaluation parameters shown in Table No 
C) Dissolution studies:
Dissolution studies were performed using a dissolution test apparatus USP XXII. (Basket assembly) at 100 rpm using 750 ml of acetate buffer(pH-4.0) and temperature was maintained at 37+ 0.5 0 through out the study. Ten millimeter of the sample was withdrawn at a regular interval and replaced with an equal volume of phosphate buffer. Samples were filtered and drug content was estimated by UV spectrophotometer at 278nm. Dissolution data shown in table 4 
III. Result and Discussion
The formulated tablets were evaluated & taken for statistical analysis study.it shows an efficient formulation for roxithromycin using 4% cross caramellose which gives hardness4.89+0.12kg/cm2.%friability0.85&%release within 10mints was found to be 95.84+1.35,disintegration time15"+0.01mintswith95+0.02%drug content.all tablets were formulated with direct compression method.stability studies with this prepared formulation were also performed.the reproducibility of formulation were also checkedby preparing 4 different batches.the %yeild was found to beuniform with low sd values.anova test was also performed for checking the dissolution test which is indicating reproducibility for f13(roxithromycin with cross caramellose) The % drug content was found to be between 99.00% to 100.00%, which was within acceptable limits. The hardness was found to be 2.5Kg/ cm 2 to 4.0 Kg/ cm 2 , Percent friability was less than 1% in the entire formulation and values obtained lies between 0.28 -0.52. All the formulations disintegrated between 31-80 seconds The study reveals that formulations prepare shows an efficient formulation d by using 5% cross caremalloose exhibited good dissolution and uniform dispersion characteristics necessary for dispersion tablets as compared tomarketed, convential tablets of roxithrocin.
IV. Conclusion
In conclusion, overall result suggests that a 5% cross caramellose shows better disintegration as compared to marketed tablet.
V.
